Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agios Pharmaceuticals (AGIO) Prepaid Assets (2016 - 2025)

Agios Pharmaceuticals (AGIO) has disclosed Prepaid Assets for 13 consecutive years, with $44.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Prepaid Assets rose 9.87% year-over-year to $44.1 million, compared with a TTM value of $44.1 million through Dec 2025, up 9.87%, and an annual FY2025 reading of $44.1 million, up 9.87% over the prior year.
  • Prepaid Assets was $44.1 million for Q4 2025 at Agios Pharmaceuticals, up from $43.2 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $46.5 million in Q3 2022 and bottomed at $19.5 million in Q1 2021.
  • Average Prepaid Assets over 5 years is $38.1 million, with a median of $39.6 million recorded in 2021.
  • Peak annual rise in Prepaid Assets hit 150.71% in 2021, while the deepest fall reached 33.07% in 2021.
  • Year by year, Prepaid Assets stood at $39.8 million in 2021, then decreased by 2.21% to $39.0 million in 2022, then decreased by 10.1% to $35.0 million in 2023, then grew by 14.69% to $40.2 million in 2024, then increased by 9.87% to $44.1 million in 2025.
  • Business Quant data shows Prepaid Assets for AGIO at $44.1 million in Q4 2025, $43.2 million in Q3 2025, and $44.7 million in Q2 2025.